MLTX earnings date and last-quarter result: last quarter miss, P/E -4.88. Updated 2026-07-23.
MoonLake Immunotherapeutics (MLTX) Research Hub
MoonLake Immunotherapeutics (MLTX) trades on NASDAQ, CH in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 11.81 USD (-0.34%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.88, market cap 1.58B. This hub links to the full technical, earnings and options research available for MLTX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CH |
| Last close | 11.81 USD (-0.34%) |
| 52-week range | 9.46 USD – 23.29 USD |
| Trend regime | Range |
| 14-day RSI | 57.9 (Bullish) |
| Trailing P/E | -4.88 |
| Market cap | 1.58B |
| Dividend yield | 0.00% |
Available research for MLTX
Covered Call on MLTX: how it works, illustrative setup around the real 11.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MLTX: how it works, illustrative setup around the real 11.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MLTX: how it works, illustrative setup around the real 11.81 USD price, max profit/loss, breakeven and when to use it. Educational.
MLTX technical analysis: range, last 11.81 USD, RSI 57.9, 52w range 9.46 USD–23.29 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MLTX in?
MoonLake Immunotherapeutics (MLTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, CH.
Is MLTX in an uptrend or downtrend?
As of 2026-10-26, MLTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MLTX's trailing P/E ratio?
MLTX's trailing P/E is -4.88, with a market cap of 1.58B. See the earnings research page for full valuation detail.